This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Proteostasis Therapeutics (treatments for genetic and degenerative diseases) brought in $45mm through its Series A round. Seed investor HealthCare Ventures returned, and was joined by new participants Fidelity Biosciences, New Enterprise Associates, Novartis Option Fund, and Genzyme Ventures.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?